Skip to content

Treatment for depression and anxiety in visually impaired older adults.

Stepped-care to reduce depression and anxiety in visually impaired older adults: A randomised controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22928
Enrollment
230
Registered
2012-02-13
Start date
2012-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

The participants will be randomly assigned to a treatment (stepped-care program) or a control group (usual care). The stepped-care programme consists of four steps which each last 3 months. Participan
2. A cognitive behaviour therapy–based bibliotherapy. Participants will receive a telephone call by a trained occupational therapist to explain the second step programme and to make an appointment for
3. Brief cognitive behaviour therapy – based problem-solving treatment (PST). Again, participants will receive information about the intervention by telephone. If the participant agrees, a trained psy
4. The last step is referral to professional treatment elsewhere, if required. The intervention is developed and implemented in two Dutch and one Belgian rehabilitation centre for the visually impair

Sponsors

VU University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Informed consent of the participants; 2. Participants must be visually impaired and entered one of the three low vision rehabilitation centres; 3. Participants must be 50 years or older; 4. Participants must be able to speak Dutch; 5. Participants must have subthreshold depression and/or anxiety, measured with a CES-D score (Center for Epidemiologic Studies Depression) and the HADS-A (Hospital Anxiety and Depression scale section A).

Exclusion criteria

Exclusion criteria: 1. Participants with severely impaired cognitive functioning, which will be detected with the 'six-item screener' (a shortened version of the MMSE (Mini-mental state examination) at baseline; 2. Participants with a DSM-IV psychiatric disorder, measured by the Mini (Mini International Neuropsychiatric Interview).

Design outcomes

Primary

MeasureTime frame
The main study parameter is the cumulative incidence of DSM-IV major depressive or anxiety disorder after 24 months as measured using the Mini International Neuropsychiatric Interview.

Secondary

MeasureTime frame
Secundary dependent variables are: 1. Subthreshold depression and/or anxiety symptoms; 2. Vision and health-related quality of life and adaptation to vision loss; 3. Process-evaluation outcomes; 4. Cost measurement and valuation. Secundary independent variables are: 1. Socio-demographic and disease variables (age, gender, education, cognitive functioning, co-morbidity, care and low vision aids received in the past half year of the rehabilitation centres etc.).

Contacts

Public ContactH.P.A. Aa, van der

De Boelelaan 1117

h.vanderaa@vumc.nl+31 (0)20 4445064

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)